CAS: 116649-85-5 - Ramatroban

Formel: C₂₁H₂₁FN₂O₄S

InChl: InChI=1S/C21H21FN2O4S/c22-14-5-8-16(9-6-14)29(27,28)23-15-7-10-20-18(13-15)17-3-1-2-4-19(17)24(20)12-11-21(25)26/h1-6,8-9,15,23H,7,10-13H2,(H,25,26)/t15-/m1/s1

InChI Key: InChIKey=LDXDSHIEDAPSSA-OAHLLOKOSA-N

SMILES: O=C(O)CCN1C=2C=CC=CC2C3=C1CCC(NS(=O)(=O)C4=CC=C(F)C=C4)C3

Synonyme:

• (3R)-3-[[(4-Fluorophenyl)sulfonyl]amino]-1,2,3,4-tetrahydro-9H-carbazole-9-propanoic acid
• 3-[(3R)-3-[(4-Fluorophenyl)sulfonylamino]-1,2,3,4-tetrahydrocarbazol-9-yl]propanoic acid
• 3-[(3R)-3-{[(4-fluorophenyl)sulfonyl]amino}-1,2,3,4-tetrahydro-9H-carbazol-9-yl]propanoic acid
• 3R-[[(4-Fluorophenyl)sulfonyl]amino]-1,2,3,4-tetrahydro-9H-carbazole-9-propanoic acid
• 9H-Carbazole-9-propanoic acid, 3-[[(4-fluorophenyl)sulfonyl]amino]-1,2,3,4-tetrahydro-, (3R)-
• 9H-Carbazole-9-propanoic acid, 3-[[(4-fluorophenyl)sulfonyl]amino]-1,2,3,4-tetrahydro-, (R)-
• BAY-u 3405
• Baynas

Ramatroban

CAS: 116649-85-5

Ramatroban (BAY u3405) (BAY u3405) is a thromboxane A(2) (TxA(2)) antagonist marketed for allergic rhinitis.

• Formel: C₂₁H₂₁FN₂O₄S
• Reinheit: 99.96%
• Farbe und Form: Crystalline Solid
• Molekulargewicht: 416.47

9H-Carbazole-9-propanoic acid, 3-[[(4-fluorophenyl)sulfonyl]amino]-1,2,3,4-tetrahydro-, (3R)-

CAS: 116649-85-5

• Formel: C₂₁H₂₁FN₂O₄S
• Reinheit: 98%
• Farbe und Form: Solid
• Molekulargewicht: 416.4658

Ramatroban

CAS: 116649-85-5

• Formel: C₂₁H₂₁FN₂O₄S
• Molekulargewicht: 416.47

Ramatroban-d4

CAS: 116649-85-5

• Formel: C₂₁H₁₇D₄FN₂O₄S
• Farbe und Form: White To Off-White Solid
• Molekulargewicht: 420.49

Ramatroban

CAS: 116649-85-5

• Formel: C₂₁H₂₁FN₂O₄S
• Reinheit: >95.0%(T)(HPLC)
• Farbe und Form: White to Light yellow to Light orange powder to crystal
• Molekulargewicht: 416.47

Ramatroban

CAS: 116649-85-5

• Formel: C₂₁H₂₁FN₂O₄S
• Molekulargewicht: 416.47

Ramatroban

CAS: 116649-85-5

Dual inhibitor of thromboxane receptor and DP2 postanoid receptor

• Formel: C₂₁H₂₁FN₂O₄S
• Reinheit: Min. 95%
• Molekulargewicht: 416.47 g/mol

Ramatroban

CAS: 116649-85-5

Applications A thromboxane receptor antagonist for use in the treatment of coronary artery disease. References …

• Formel: C₂₁H₂₁FN₂O₄S
• Farbe und Form: Neat
• Molekulargewicht: 416.47